Rasha Al-Lamee
@rallamee
Interventional Cardiology Consultant, Clinical Trialist, Imperial College London. Wife to a rugby obsessed husband and mum to a football obsessed son
ID: 916585888574042113
07-10-2017 08:47:59
1,1K Tweet
5,5K Takipçi
530 Takip Edilen
Excellent discussion of ORBITA-STAR by Michael Chen Simple findings like those made in this study pave the way to solve a major clinical problem. In stable patients, persistent angina is PCI’s Achilles’ heel TCTMD PCRonline 🫀 Rasha Al-Lamee
#ORBITA-STAR: Symptom-to-stenosis mapping may allow #PCI to be targeted to those most likely to benefit. Learn more in #JACC: bit.ly/4bfHcoJ #CardioTwitter Christopher Rajkumar Rasha Al-Lamee Michael Foley via JACC Journals
Watch This Week's Episode of OPCI Journal Club: “ORBITA-STAR Trial and the ORBITA II Symptoms Analysis” presented by Rasha Al-Lamee Christopher Rajkumar and Florentina Simader. Joined by panelists David J. Cohen, MD, MSc Dr. Jeffrey W. Moses Evan Shlofmitz and Dr. Lawrence Garcia. opci.live/journal-club/ #cardiotwitter
🚨Breaking News: New ESC Guidelines on CCS. Intracoronary Imaging now Class IA for LM, true bifurcation and long lesions! Either OCT or IVUS. PCRonline 🫀 European Society of Cardiology Niels R. Holm Tom Johnson Nicolas Amabile Flavio Biccirè Ziad Ali Prof. Hector M. Garcia-Garcia Salvatore Brugaletta Holger Nef
Today at #ESCCongress in London: #JACC Deputy Editor @Rallamee revealed the motivation for the The Lancet Commission on #ASCVD, as rates of disease continue to rise ↗️ despite the increase in investment. Result to come at #ACC25!
What a moment! The Lancet Editor richard horton and #JACC Editor Harlan Krumholz came together to celebrate the new partnership between the Journals. A rare opportunity for the two platforms to come together to improve CV care!
“Research will help other people in the future get the best treatment.” This #Red4Research day, we are celebrating the patients who make clinical trials possible ❤️ Syed took part in the innovative ORBITA clinical trial, supported by NIHR Imperial BRC ➡️ youtube.com/watch?v=GgVB-d…
Always a pleasure to work with the lovely patients Imperial NHS 💙 who make research possible #Red4Research ❤️❤️ But also the brilliant Rasha Al-Lamee who leads on this unique set of NIHR Imperial BRC funded studies, which could offer patients with angina more options for treatment.
Always love coming down to Portsmouth! Excellent cases done in record timing and a super fun team to work with! Thank you Peter Haworth Brijesh Anantharam for having us Rasha Al-Lamee
It was such a pleasure to join Rasha Al-Lamee to talk all things ESC 2024 Thank you so much The Lancet #chloewilson open.spotify.com/episode/5AeJOc…
Michael foley presenting orbita 2 analysis showing that ffr and ifr predict angina benefit from pci. Absolute values matter more than dichotimous cutoff. I would personally like to see how microvascular function fits into this Rasha Al-Lamee MIЯVΛƬ #IC Omar Khalique Hany Ragy
ORBITA CTO pilot is in the final phase of recruitment. 6 month blinded follow up required. Will allow early understanding of true CTO PCI effect size with ORBITA App. John Davies Dr S Khan Rasha Al-Lamee EssexCTC Essex Heart Fund 💛 MSE Research Team 💙
This is the key. We think death from coronary disease is 80% preventable by 2050. We spent 2.5 years developing this blueprint and we pledge to spend the next 25 years making it happen! The Lancet
From CAD to atherosclerotic coronary artery disease? The Lancet Commission led by Rasha Al-Lamee includes Davide Capodanno EuroIntervention Editor-in-Chief , MIЯVΛƬ #IC PCRonline Editorial Board member, Nieves Gonzalo #EuroPCR Course Director, and Nicole Karam, MD, PhD, FESC PCR Innovators Day